These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15971608)

  • 21. Agonist-specific down regulation of mu-opioid receptors: Different cellular pathways are activated by different opioid agonists.
    Binyaminy B; Gafni M; Shapira M; Sarne Y
    Life Sci; 2008 Apr; 82(15-16):831-9. PubMed ID: 18358497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficient, stable expression of human interleukin-15 cDNA in Chinese hamster oval cells].
    Xue L; Cui L; He W; Ba D
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Aug; 21(4):293-7. PubMed ID: 12567453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RGSZ1 interacts with protein kinase C interacting protein PKCI-1 and modulates mu opioid receptor signaling.
    Ajit SK; Ramineni S; Edris W; Hunt RA; Hum WT; Hepler JR; Young KH
    Cell Signal; 2007 Apr; 19(4):723-30. PubMed ID: 17126529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Establishment and identification of stable transfection of CHO and COS7 cells with TIF3cDNA].
    Lei Y; Pius J; Liu Y; Tong-man O
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jan; 34(1):55-7. PubMed ID: 15600179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and pharmacological evaluation of novel octahydro-1H-pyrido[1,2-a]pyrazine as mu-opioid receptor antagonists.
    Le Bourdonnec B; Goodman AJ; Graczyk TM; Belanger S; Seida PR; DeHaven RN; Dolle RE
    J Med Chem; 2006 Dec; 49(25):7290-306. PubMed ID: 17149859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An investigation of the N-demethylation of 3-deoxymorphine and the affinity of the alkylation products to mu, delta, and kappa receptors.
    Csutoras C; Zhang A; Bidlack JM; Neumeyer JL
    Bioorg Med Chem; 2004 May; 12(10):2687-90. PubMed ID: 15110850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-cell receptor/CD28-mediated activation of human T lymphocytes induces expression of functional mu-opioid receptors.
    Börner C; Kraus J; Bedini A; Schraven B; Höllt V
    Mol Pharmacol; 2008 Aug; 74(2):496-504. PubMed ID: 18463202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of MOR1C-like mu-opioid receptor mRNA in rats.
    Schnell SA; Wessendorf MW
    J Comp Neurol; 2004 May; 473(2):213-32. PubMed ID: 15101090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain.
    Endres-Becker J; Heppenstall PA; Mousa SA; Labuz D; Oksche A; Schäfer M; Stein C; Zöllner C
    Mol Pharmacol; 2007 Jan; 71(1):12-8. PubMed ID: 17005903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Construction of mammalian cell expression vector for pAcGFP-bFADD fusion protein and its expression in CHO-K1 cell].
    Yang R; Xu S; Zhang L; Li J; Gao X
    Sheng Wu Gong Cheng Xue Bao; 2008 Nov; 24(11):1880-7. PubMed ID: 19256333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasticity of adenylyl cyclase-related signaling sequelae after long-term morphine treatment.
    Shy M; Chakrabarti S; Gintzler AR
    Mol Pharmacol; 2008 Mar; 73(3):868-79. PubMed ID: 18045853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes.
    Lester PA; Traynor JR
    Brain Res; 2006 Feb; 1073-1074():290-6. PubMed ID: 16443205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expressed mu opiate receptor couples to adenylate cyclase and phosphatidyl inositol turnover.
    Johnson PS; Wang JB; Wang WF; Uhl GR
    Neuroreport; 1994 Jan; 5(4):507-9. PubMed ID: 8003685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bioassay of the soluble human tumor necrosis factor receptor I recombinant plasmid expression in vitro].
    Xu CR; Zhang JC; Zhao CJ; Zhang YH
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 May; 39(3):185-8. PubMed ID: 15196381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of chronic treatment of ohmefentanyl stereoisomers on cyclic AMP formation in Sf9 insect cells expressing human mu-opioid receptors.
    Liu ZH; He Y; Jin WQ; Chen XJ; Shen QX; Chi ZQ
    Life Sci; 2004 Apr; 74(24):3001-8. PubMed ID: 15051423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developmental expression and distribution of opioid receptors in zebrafish.
    Sanchez-Simon FM; Rodriguez RE
    Neuroscience; 2008 Jan; 151(1):129-37. PubMed ID: 18082336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and pharmacological characterization of a novel, highly potent, peptidomimetic delta-opioid radioantagonist, [3H]Tyr-Tic-(2S,3R)-beta-MePhe-Phe-OH.
    Birkas E; Kertesz I; Toth G; Bakota L; Gulya K; Szucs M
    Neuropeptides; 2008 Feb; 42(1):57-67. PubMed ID: 18068762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphine desensitization, internalization, and down-regulation of the mu opioid receptor is facilitated by serotonin 5-hydroxytryptamine2A receptor coactivation.
    Lopez-Gimenez JF; Vilaró MT; Milligan G
    Mol Pharmacol; 2008 Nov; 74(5):1278-91. PubMed ID: 18703670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of human dopamine D1-like receptor agonist using a cell-based functional assay.
    Jiang N; Ou-Yang KQ; Cai SX; Hu YH; Xu ZL
    Acta Pharmacol Sin; 2005 Oct; 26(10):1181-6. PubMed ID: 16174433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.